Most-Cited Articles as of July 1, 2017 -- updated monthly

Rankings based on citations to online articles from HighWire-hosted articles.

  1. Research Article: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    • A Adachi,
    • H E Gendelman,
    • S Koenig,
    • T Folks,
    • R Willey,
    • A Rabson,
    • and M A Martin
    J. Virol. August 1986 59:2 284-291
  2. Research Article: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    • R A Koup,
    • J T Safrit,
    • Y Cao,
    • C A Andrews,
    • G McLeod,
    • W Borkowsky,
    • C Farthing,
    • and D D Ho
    J. Virol. July 1994 68:7 4650-4655
  3. Research Article: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    • P Borrow,
    • H Lewicki,
    • B H Hahn,
    • G M Shaw,
    • and M B Oldstone
    J. Virol. September 1994 68:9 6103-6110
  4. GENE THERAPY: A Third-Generation Lentivirus Vector with a Conditional Packaging System
    • Tom Dull,
    • Romain Zufferey,
    • Michael Kelly,
    • R. J. Mandel,
    • Minh Nguyen,
    • Didier Trono,
    • and Luigi Naldini
    J. Virol. November 1998 72:11 8463-8471
  5. PATHOGENESIS AND IMMUNITY: Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment
    • E. John Wherry,
    • Joseph N. Blattman,
    • Kaja Murali-Krishna,
    • Robbert van der Most,
    • and Rafi Ahmed
    J. Virol. April 2003 77:8 4911-4927; doi:10.1128/JVI.77.8.4911-4927.2003
  6. Research Article: CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    • M Matloubian,
    • R J Concepcion,
    • and R Ahmed
    J. Virol. December 1994 68:12 8056-8063
  7. Research Article: A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.
    • S K Jang,
    • H G Kräusslich,
    • M J Nicklin,
    • G M Duke,
    • A C Palmenberg,
    • and E Wimmer
    J. Virol. August 1988 62:8 2636-2643
  8. VIRUS-CELL INTERACTIONS: Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1
    • Emily J. Platt,
    • Kathy Wehrly,
    • Shawn E. Kuhmann,
    • Bruce Chesebro,
    • and David Kabat
    J. Virol. April 1998 72:4 2855-2864
  9. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
    • A Trkola,
    • M Purtscher,
    • T Muster,
    • C Ballaun,
    • A Buchacher,
    • N Sullivan,
    • K Srinivasan,
    • J Sodroski,
    • J P Moore,
    • and H Katinger
    J. Virol. February 1996 70:2 1100-8
  10. Research Article: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.
    • J Kimpton and
    • M Emerman
    J. Virol. April 1992 66:4 2232-2239
  11. VACCINES AND ANTIVIRAL AGENTS: Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
    • Ming Li,
    • Feng Gao,
    • John R. Mascola,
    • Leonidas Stamatatos,
    • Victoria R. Polonis,
    • Marguerite Koutsoukos,
    • Gerald Voss,
    • Paul Goepfert,
    • Peter Gilbert,
    • Kelli M. Greene,
    • Miroslawa Bilska,
    • Denise L. Kothe,
    • Jesus F. Salazar-Gonzalez,
    • Xiping Wei,
    • Julie M. Decker,
    • Beatrice H. Hahn,
    • and David C. Montefiori
    J. Virol. August 2005 79:16 10108-10125; doi:10.1128/JVI.79.16.10108-10125.2005
  12. Construction of adenovirus vectors through Cre-lox recombination.
    • S Hardy,
    • M Kitamura,
    • T Harris-Stansil,
    • Y Dai,
    • and M L Phipps
    J. Virol. March 1997 71:3 1842-9
  13. RECOMBINATION AND EVOLUTION: Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination
    • Kavita S. Lole,
    • Robert C. Bollinger,
    • Ramesh S. Paranjape,
    • Deepak Gadkari,
    • Smita S. Kulkarni,
    • Nicole G. Novak,
    • Roxann Ingersoll,
    • Haynes W. Sheppard,
    • and Stuart C. Ray
    J. Virol. January 1999 73:1 152-160
  14. Complete sequence and genomic analysis of murine gammaherpesvirus 68.
    • H W Virgin 4th,
    • P Latreille,
    • P Wamsley,
    • K Hallsworth,
    • K E Weck,
    • A J Dal Canto,
    • and S H Speck
    J. Virol. August 1997 71:8 5894-904
  15. REPLICATION: Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV Genome Promoter
    • Ursula J. Buchholz,
    • Stefan Finke,
    • and Karl-Klaus Conzelmann
    J. Virol. January 1999 73:1 251-259
  16. REPLICATION: Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
    • Keril J. Blight,
    • Jane A. McKeating,
    • and Charles M. Rice
    J. Virol. December 2002 76:24 13001-13014; doi:10.1128/JVI.76.24.13001-13014.2002
  17. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.
    • R K Naviaux,
    • E Costanzi,
    • M Haas,
    • and I M Verma
    J. Virol. August 1996 70:8 5701-5
  18. Research Article: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.
    • H Schuitemaker,
    • M Koot,
    • N A Kootstra,
    • M W Dercksen,
    • R E de Goede,
    • R P van Steenwijk,
    • J M Lange,
    • J K Schattenkerk,
    • F Miedema,
    • and M Tersmette
    J. Virol. March 1992 66:3 1354-1360
  19. Research Article: A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.
    • T Muster,
    • F Steindl,
    • M Purtscher,
    • A Trkola,
    • A Klima,
    • G Himmler,
    • F Rüker,
    • and H Katinger
    J. Virol. November 1993 67:11 6642-6647
  20. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.
    • J He,
    • S Choe,
    • R Walker,
    • P Di Marzio,
    • D O Morgan,
    • and N R Landau
    J. Virol. November 1995 69:11 6705-11

Last updated 07/03/2017 21:50:01

current issue

    July 2017, volume 91, issue 14
  1. Current Issue
  1. Alert me to new issues of JVI